Home

RICHARD B SLANSKY

CIK 1224981 · Chief Financial Officer · last filed 2026-04-01

RICHARD B SLANSKY is a Chief Financial Officer who has filed 34 SEC Form 4 insider transactions across 4 companies since 2009. The most recent filing, for GNTA, was dated Apr 1, 2026. Across all open-market trades the lifetime net is +$866.1K, making them a net buyer over the disclosed history. 15 SEC filings were submitted jointly with STAR EQUITY HOLDINGS, INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

34

Lifetime Open-Market Net

$866.1K

Filer Profile

Reported Address
5820 NANCY RIDGE DRIVE
SAN DIEGO, CA 92121
Related Filers
STAR EQUITY HOLDINGS, INC. — 15 joint filings, latest 2012-04-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
GNTA Chief Financial Officer — $0.65 — $0 1 2026-04-01
ONCOSEC MEDICAL Inc (ONCS) Delisted Chief Financial Officer 1,269 $0.28 $352 $799.5K 8 2018-07-06
GenMark Diagnostics, Inc. (GNMK) Delisted Chief Financial Officer 111,836 $24.04 $2.69M $66.5K 10 2014-03-13
STAR EQUITY HOLDINGS, INC. (DRAD) Delisted Chief Financial Officer 2,904 — — $0 14 2012-04-12

Recent Filings

34 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-04-01 GNTA Grant (A) — $0 EDGAR
2018-07-06 ONCOSEC MEDICAL Inc (ONCS) Delisted Mixed +115,016 -$118.5K EDGAR
2018-05-07 ONCOSEC MEDICAL Inc (ONCS) Delisted Grant (A) — $0 EDGAR
2018-01-17 ONCOSEC MEDICAL Inc (ONCS) Delisted Grant (A) — $0 EDGAR
2017-03-31 ONCOSEC MEDICAL Inc (ONCS) Delisted Grant (A) — $0 EDGAR
2016-12-16 ONCOSEC MEDICAL Inc (ONCS) Delisted Mixed — $0 EDGAR
2016-03-08 ONCOSEC MEDICAL Inc (ONCS) Delisted Grant (A) — $0 EDGAR
2015-08-24 ONCOSEC MEDICAL Inc (ONCS) Delisted Grant (A) — $0 EDGAR
2015-07-08 ONCOSEC MEDICAL Inc (ONCS) Delisted Buy (P) +150,000 $918.0K EDGAR
2014-03-13 GenMark Diagnostics, Inc. (GNMK) Delisted Sell (S) −1,680 -$20.4K EDGAR
Showing 1–10 of 34
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.